Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kymera Therapeutics (KYMR) Other Operating Expenses (2024 - 2025)

Historic Other Operating Expenses for Kymera Therapeutics (KYMR) over the last 2 years, with Q3 2025 value amounting to $3.9 million.

  • Kymera Therapeutics' Other Operating Expenses changed N/A to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 2172.59%. This contributed to the annual value of $4.9 million for FY2024, which is N/A changed from last year.
  • Kymera Therapeutics' Other Operating Expenses amounted to $3.9 million in Q3 2025.
  • Over the past 5 years, Kymera Therapeutics' Other Operating Expenses peaked at $4.9 million during Q1 2024, and registered a low of $3.9 million during Q3 2025.